Inventor · disambiguated record
Leslie P. Miranda
Also filed as: MIRANDA LESLIE P · MIRANDA LESLIE PHILLIP
26 granted patents·5 pending applications·275 citations·filing 2006–2025
95Inventor score
Top patents by PatentIndex Score
31 records- 0196US8008453B2Modified Fc moleculesAMGEN INC·Filed 2006·Granted Aug 30, 2011·55 cites·19 claims
- 0296US7803769B2OSK1 peptide analogs and pharmaceutical compositionsAMGEN INC·Filed 2007·Granted Sep 28, 2010·46 cites·3 claims
- 0395US7833979B2Toxin peptide therapeutic agentsAMGEN INC·Filed 2006·Granted Nov 16, 2010·45 cites·31 claims
- 0494US8907071B2Toxin peptide therapeutic agentsSULLIVAN JOHN K·Filed 2010·Granted Dec 9, 2014·61 cites·24 claims
- 0590US10905772B2Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2018·Granted Feb 2, 2021·6 cites·18 claims
- 0689US7834164B2DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expressionAMGEN INC·Filed 2007·Granted Nov 16, 2010·9 cites·8 claims
- 0789US7820623B2Conjugated toxin peptide therapeutic agentsAMGEN INC·Filed 2007·Granted Oct 26, 2010·10 cites·23 claims
- 0885US8043829B2DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expressionAMGEN INC·Filed 2007·Granted Oct 25, 2011·6 cites·19 claims
- 0984US8168592B2CGRP peptide antagonists and conjugatesGEGG JR COLIN V·Filed 2006·Granted May 1, 2012·23 cites·11 claims
- 1083US7825093B2Methods of using OSK1 peptide analogsAMGEN INC·Filed 2007·Granted Nov 2, 2010·4 cites·3 claims
- 1182US7910102B2Methods of using conjugated toxin peptide therapeutic agentsAMGEN INC·Filed 2007·Granted Mar 22, 2011·4 cites·12 claims
- 1280US2024327461A1Apelin polypeptidesAMGEN INC·Filed 2024·Application pending·0 cites
- 1380US2025121056A1Method of treating or ameliorating metabolic disorders using glp-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (gipr)AMGEN INC·Filed 2024·Application pending·0 cites
- 1474US11807693B2Apelin polypeptidesAMGEN INC·Filed 2021·Granted Nov 7, 2023·0 cites·6 claims
- 1573US11266744B2Modified Fc moleculesAMGEN INC·Filed 2018·Granted Mar 8, 2022·0 cites·24 claims
- 1671US9340590B2Potent and selective inhibitors of NaV1.3 and NaV1.7MURRAY JUSTIN K·Filed 2012·Granted May 17, 2016·4 cites·40 claims
- 1769US12214051B2Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2021·Granted Feb 4, 2025·0 cites·14 claims
- 1868US8288339B2GLP-1 compoundsGEGG JR COLIN VICTOR·Filed 2007·Granted Oct 16, 2012·2 cites·7 claims
- 1967US11732266B2RNAi constructs for inhibiting ASGR1 expression and methods of use thereofAMGEN INC·Filed 2020·Granted Aug 22, 2023·0 cites·34 claims
- 2059US10941182B2Apelin polypeptidesAMGEN INC·Filed 2015·Granted Mar 9, 2021·0 cites·26 claims
- 2157US10870856B2RNAi constructs for inhibiting ASGR1 expression and methods of use thereofAMGEN INC·Filed 2017·Granted Dec 22, 2020·0 cites·36 claims
- 2256US10188740B2Modified Fc moleculesAMGEN INC·Filed 2015·Granted Jan 29, 2019·0 cites·33 claims
- 2349US9114175B2Modified Fc moleculesGEGG COLIN V·Filed 2011·Granted Aug 25, 2015·0 cites·21 claims
- 2449US2025276080A1Glucagon receptor agonists and conjugates to glucose-dependent insulinotropic polypeptide antagonistsAMGEN INC·Filed 2025·Application pending·0 cites
- 2548US11643440B2Peptide PAC1 antagonistsAMGEN INC·Filed 2018·Granted May 9, 2023·0 cites·4 claims
- 2646US9636418B2Potent and selective inhibitors of NAV1.7AMGEN INC·Filed 2014·Granted May 2, 2017·0 cites·24 claims
- 2743US10344060B2Potent and selective inhibitors of Nav1.7AMGEN INC·Filed 2014·Granted Jul 9, 2019·0 cites·25 claims
- 2843US9796766B2Potent and selective inhibitors of NAV1.3 and NAV1.7AMGEN INC·Filed 2016·Granted Oct 24, 2017·0 cites·44 claims
- 2943US2016067347A1Apj receptor agonists and uses thereofAMGEN INC·Filed 2013·Application pending·0 cites
- 3041US2013203659A1Glp-1 compoundsMIRANDA LESLIE P·Filed 2012·Application pending·0 cites
- 3137US9012178B2Dipeptides to enhance yield and viability from cell culturesKANG SOHYE·Filed 2011·Granted Apr 21, 2015·0 cites·24 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →